Market volatility has risen sharply as investors react to short-term geopolitical newsIn the biotech sector, however, investment experts tend to remain focused on long-term developments such as clinical drug trialsFor those with a long-term horizon, here are some favorites from MoneyShow.com contributorsDrJoe Duarte, In the Money Options AstraZene...
You have reached your free article limit. Try Real Money Free for 14 Days to continue reading this story and get access to money-making ideas.
Stay ahead of the market with Real Money where you'll get actionable investing ideas from over 30+ investing pros, money managers, journalists and analysts. Real Money allows you to interact directly with experts that give you a flood of opinions, analysis and trading advice found nowhere else.